China Digest: GGV leads $14m in Rongyisuan; Hugo Biotech raises funding

GGV Capital has led a Series A+ round of nearly 100 million yuan ($14 million) in Chinese tax and accounting startup Rongyisuan, while Beijing-based Hugo Biotech has also raised almost 100 million yuan ($14 million) in its first funding round.